{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:04:54Z","timestamp":1782241494605,"version":"3.54.5"},"reference-count":136,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00248","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T03:51:35Z","timestamp":1497239495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Parasite Carbohydrate Vaccines"],"prefix":"10.3389","volume":"7","author":[{"given":"Jonnel A.","family":"Jaurigue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Seeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/cbic.200700310","article-title":"Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells","volume":"9","author":"Adams","year":"2008","journal-title":"Chembiochem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1039\/C0SC00322K","article-title":"Comparative bioinformatics analysis of the mammalian and bacterial glycomes","volume":"2","author":"Adibekian","year":"2011","journal-title":"Chem. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fimmu.2014.00260","article-title":"Leishmania spp. proteome data sets: a comprehensive resource for vaccine development to target visceral leishmaniasis","volume":"5","author":"Aebischer","year":"2014","journal-title":"Front. Immun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1021\/cb400602k","article-title":"Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of leishmania","volume":"8","author":"Anish","year":"2013","journal-title":"Acs Chem. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chembiol.2014.01.002","article-title":"Chemical biology approaches to designing defined carbohydrate vaccines","volume":"21","author":"Anish","year":"2014","journal-title":"Chem. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against new world cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1543","DOI":"10.1371\/journal.pntd.0001543","article-title":"Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure","volume":"6","author":"Assis","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat Rev. Drug Discov"},{"key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-immunol-030409-101159","article-title":"How bacterial carbohydrates influence the adaptive immune system","volume":"28","author":"Avci","year":"2010","journal-title":"Annu. Rev. Immun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.54.3.437","article-title":"Chemo-immunological studies on conjugated carbohydrate-proteins: V. the immunological specifity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein","volume":"54","author":"Avery","year":"1931","journal-title":"J. Exp. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/eji.200526146","article-title":"The influence of natural antibody specificity on antigen immunogenicity","volume":"35","author":"Benatuil","year":"2005","journal-title":"Eur. J. Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1021\/cb400423g","article-title":"Recent mechanistic insights on glycoconjugate vaccines and future perspectives","volume":"8","author":"Berti","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/IAI.37.1.15-22.1982","article-title":"Comparison of the induction of immunoglobulin-M and immunoglobulin-G antibodies in mice with purified pneumococcal type-3 and meningococcal group-C polysaccharides and their protein conjugates","volume":"37","author":"Beuvery","year":"1982","journal-title":"Infect. Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2180-14-8","article-title":"IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine","volume":"14","author":"Bhowmick","year":"2014","journal-title":"BMC Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"23R","DOI":"10.1093\/glycob\/cwm005","article-title":"Evolution of carbohydrate antigens \u2014 microbial forces shaping host glycomes?","volume":"17","author":"Bishop","year":"2007","journal-title":"Glycobiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri3167","article-title":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat","volume":"12","author":"Blander","year":"2012","journal-title":"Nat. Rev. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1128\/IAI.70.9.5052-5057.2002","article-title":"Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults","volume":"70","author":"Boutlis","year":"2002","journal-title":"Infect. Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/3-540-29967-x_5","article-title":"Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination","volume":"297","author":"Boutlis","year":"2005","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/JCM.28.2.265-268.1990","article-title":"Impairment of Plasmodium-falciparum-specific antibody-response in severe malaria","volume":"28","author":"Brasseur","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.1038\/ncomms11224","article-title":"Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans","volume":"7","author":"Broecker","year":"2016","journal-title":"Nat. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1002\/chem.200400074","article-title":"The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein","volume":"10","author":"Buskas","year":"2004","journal-title":"Chem. Eur. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2224","DOI":"10.1371\/journal.pntd.0002224","article-title":"Leishmania mexicana infection induces igg to parasite surface glycoinositol phospholipids that can induce il-10 in mice and humans","volume":"7","author":"Buxbaum","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/vaccines5010004","article-title":"From immunologically archaic to neoteric glycovaccines","volume":"5","author":"Cavallari","year":"2017","journal-title":"Vaccines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nchembio.1650","article-title":"A semisynthetic carbohydrate-lipid vaccine that protects against S-pneumoniae in mice","volume":"10","author":"Cavallari","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4269\/ajtmh.2006.75.199","article-title":"Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls","volume":"75","author":"Cissoko","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4269\/ajtmh.1956.5.197","article-title":"Immunity patterns in the Guinea Pig following Toxoplasma infection and vaccination with killed Toxoplasma","volume":"5","author":"Cutchins","year":"1956","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E2209","DOI":"10.1073\/pnas.1303573110","article-title":"Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens","volume":"110","author":"Cywes-Bentley","year":"2013","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pt.2010.04.006","article-title":"Glycolipids are potential targets for protozoan parasite diseases","volume":"26","author":"Debierre-Grockiego","year":"2010","journal-title":"Trends Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"32987","DOI":"10.1074\/jbc.M304791200","article-title":"Roles of glycosylphosphatidylinositols of Toxoplasma gondii - induction of tumor necrosis factor-alpha production in macrophages","volume":"278","author":"Debierre-Grockiego","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.4049\/jimmunol.179.2.1129","article-title":"Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii","volume":"179","author":"Debierre-Grockiego","year":"2007","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/glycob\/cwq038","article-title":"Immunological reactions in response to apicomplexan glycosylphosphatidylinositols","volume":"20","author":"Debierre-Grockiego","year":"2010","journal-title":"Glycobiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nri3694","article-title":"From empiricism to rational design: a personal perspective of the evolution of vaccine development","volume":"14","author":"De Gregorio","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/eji.200838648","article-title":"Alum adjuvanticity: unraveling a century old mystery","volume":"38","author":"De Gregorio","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/EC.00364-12","article-title":"Adhesins in human fungal pathogens: glue with plenty of stick","volume":"12","author":"de Groot","year":"2013","journal-title":"Eukaryotic Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1128\/IAI.70.8.4510-4522.2002","article-title":"Genes for glycosylphosphatidylinositol toxin biosynthesis in Plasmodium falciparum","volume":"70","author":"Delorenzi","year":"2002","journal-title":"Infect. Immun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1286-4579(02)01624-6","article-title":"Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection","volume":"4","author":"Descoteaux","year":"2002","journal-title":"Microb. Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1128\/IAI.00359-10","article-title":"Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individuals","volume":"78","author":"de Souza","year":"2010","journal-title":"Infect. Immun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1128\/IAI.70.9.5045-5051.2002","article-title":"Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria","volume":"70","author":"de Souza","year":"2002","journal-title":"Infect. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/00007890-199804270-00020","article-title":"A sensitive assay for measuring alpha-gal epitope expression on cells by a monoclonal anti-Gal antibody","volume":"65","author":"Galili","year":"1998","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.160.5.1519","article-title":"A unique natural human-igg antibody with anti-alpha-galactosyl specificity","volume":"160","author":"Galili","year":"1984","journal-title":"J. Exp. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","article-title":"Gene-sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys","volume":"88","author":"Galili","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/acschembio.5b00768","article-title":"Deciphering antigenic determinants of Streptococcus pneumoniae serotype 4 capsular polysaccharide using synthetic oligosaccharides","volume":"11","author":"Geissner","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-anchem-071015-041641","article-title":"Glycan arrays: from basic biochemical research to bioanalytical and biomedical applications","volume":"9","author":"Geissner","year":"2016","journal-title":"Annu. Rev. Anal. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","article-title":"A review of vaccine research and development: meningococcal disease","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1590\/0074-0276108062013018","article-title":"Asymptomatic infection in individuals from the municipality of Barcelos, (Brazilian Amazon) is not associated with the anti-Plasmodium falciparum glycosylphosphatidylinositol antibody response","volume":"108","author":"Gomes","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1001994","DOI":"10.1371\/journal.pmed.1001994","article-title":"The future of the RTS, S\/AS01 malaria vaccine: an alternative development plan","volume":"13","author":"Gosling","year":"2016","journal-title":"PLoS Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"13701","DOI":"10.1002\/anie.201406706","article-title":"Diagnosis of toxoplasmosis using a synthetic glycosylphosphatidylinositol glycan","volume":"53","author":"Gotze","year":"2014","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"B54","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/glycob\/cwv040","article-title":"Investigation of the protective properties of glycosylphosphatidylinositol-based vaccine candidates in a Toxoplasma gondii mouse challenge model","volume":"25","author":"Gotze","year":"2015","journal-title":"Glycobiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1286-4579(02)01619-2","article-title":"Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum","volume":"4","author":"Gowda","year":"2002","journal-title":"Microb. Infect."},{"key":"B56","doi-asserted-by":"publisher","first-page":"6428","DOI":"10.1074\/jbc.272.10.6428","article-title":"Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum","volume":"272","author":"Gowda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1469-0691.2012.03943.x","article-title":"A century of pneumococcal vaccination research in humans","volume":"18","author":"Grabenstein","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1021\/acs.bioconjchem.6b00542","article-title":"Toward the development of the next generation of a rapid diagnostic test: synthesis of glycophosphatidylinositol, (GPI) analogues of plasmodium falciparum and immunological characterization","volume":"27","author":"Gurale","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"0073","DOI":"10.1084\/jem.38.1.73","article-title":"The soluble specific substance of pneumococcus","volume":"38","author":"Heidelberger","year":"1923","journal-title":"J. Exp. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1084\/jem.40.3.301","article-title":"The soluble specific substance of pneumococcus second paper","volume":"40","author":"Heidelberger","year":"1924","journal-title":"J. Exp. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1016\/j.vaccine.2015.07.091","article-title":"The march toward malaria vaccines","volume":"33","author":"Hoffman","year":"2015","journal-title":"Vaccine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1039\/b708016f","article-title":"Carbohydrate arrays as tools for research and diagnostics","volume":"37","author":"Horlacher","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-642-51014-4_11","article-title":"Cells and cytokines in resistance to Toxoplasma gondii","volume":"219","author":"Hunter","year":"1996","journal-title":"Toxoplasma Gondii"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2874-3_1","article-title":"Carbohydrate-based vaccines: an overview","volume":"1331","author":"H\u00fctter","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/526787","article-title":"Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children","volume":"197","author":"John","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B68","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nchembio.75","article-title":"Synthetic GPI array to study antitoxic malaria response","volume":"4","author":"Kamena","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4269\/ajtmh.2003.69.1.0690036","article-title":"Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia","volume":"69","author":"Keenihan","year":"2003","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.ijpara.2008.06.002","article-title":"Control of the risk of human toxoplasmosis transmitted by meat","volume":"38","author":"Kijlstra","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","article-title":"Bacterial adhesins in host-microbe interactions","volume":"5","author":"Kline","year":"2009","journal-title":"Cell Host Microb."},{"key":"B72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4049\/jimmunol.108.2.425","article-title":"Use of killed vaccines in immunization against an intracellular parasite - Toxoplasma-gondii","volume":"108","author":"Krahenbuhl","year":"1972","journal-title":"J. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1074\/jbc.M413541200","article-title":"Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol, (GPI) structural requirement, and regulation of GPI activity","volume":"280","author":"Krishnegowda","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"B75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/IR:31:1:25","article-title":"The role of B cells and accessory cells in the neonatal response to TI-2 antigens","volume":"31","author":"Landers","year":"2005","journal-title":"Immunol. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The Economic value of a visceral leishmaniasis vaccine in Bihar State, India","volume":"86","author":"Lee","year":"2012","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"B77","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1007\/978-1-4939-2874-3","article-title":"Carbohydrate-based vaccines preface","volume":"1331","author":"Lepenies","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/s0264-410x(99)00232-7","article-title":"Glycoprotein conjugate vaccines","volume":"17","author":"Lindberg","year":"1999","journal-title":"Vaccine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4161\/hv.21006","article-title":"Vaccines against Toxoplasma gondii Status, challenges and future directions","volume":"8","author":"Liu","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/cb600086b","article-title":"Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate","volume":"1","author":"Liu","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/432582","article-title":"Carbohydrate moieties as vaccine candidates","volume":"41","author":"Lucas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in aids","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","article-title":"The Gal alpha 1,3Gal beta 1,4GlcNAc-R, (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance","volume":"1780","author":"Macher","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/iid3.89","article-title":"Inflammatory cytokine and humoral responses toPlasmodium falciparumglycosylphosphatidylinositols correlates with malaria immunity and pathogenesis","volume":"4","author":"Mbengue","year":"2016","journal-title":"Immun. Inflam. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1073\/pnas.84.24.8941","article-title":"Lipophosphoglycan of leishmania-major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor","volume":"84","author":"McConville","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B87","doi-asserted-by":"crossref","first-page":"15595","DOI":"10.1016\/S0021-9258(18)82298-0","article-title":"The glycoinositol phospholipids of Leishmania-Mexicana promastigotes. Evidence for the presence of 3 distinct pathways of glycolipid biosynthesis","volume":"268","author":"McConville","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B89","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1128\/IAI.57.11.3349-3356.1989","article-title":"Evidence for T-Cell Recognition in Mice of a Purified Lipophosphoglycan from Leishmania-Major","volume":"57","author":"Moll","year":"1989","journal-title":"Infect. Immun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-540-73900-5_2","article-title":"The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens","volume":"319","author":"Mond","year":"2008","journal-title":"Spec. Complement. Hum. Immun Respon. Infect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1146\/annurev.iy.13.040195.003255","article-title":"T-cell-independent antigens type-2","volume":"13","author":"Mond","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1084\/jem.192.11.1563","article-title":"Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis","volume":"192","author":"Naik","year":"2000","journal-title":"J. Exp. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/vaccines4020019","article-title":"Entirely carbohydrate-based vaccines: an emerging field for specific and selective immune responses","volume":"4","author":"Nishat","year":"2016","journal-title":"Vaccines"},{"key":"B96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.abb.2004.04.004","article-title":"Antigenic glycans in parasitic infections: implications for vaccines and diagnostics","volume":"426","author":"Nyame","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.4049\/jimmunol.178.6.3954","article-title":"Disruption of CD36 impairs cytokine response to plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo","volume":"178","author":"Patel","year":"2007","journal-title":"J. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.micinf.2005.01.002","article-title":"Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria","volume":"7","author":"Perraut","year":"2005","journal-title":"Microb. Infect."},{"key":"B99","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"Pinheiro","year":"2007","journal-title":"Vaccine"},{"key":"B102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0167-5699(90)90007-V","article-title":"The malaria vaccine: anti-parasite or anti-disease?","volume":"11","author":"Playfair","year":"1990","journal-title":"Immunol. Today"},{"key":"B103","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1128\/JCM.42.3.941-945.2004","article-title":"Recent developments for diagnosis of toxoplasmosis","volume":"42","author":"Remington","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e1005169","DOI":"10.1371\/journal.ppat.1005169","article-title":"Parasite glycobiology: a bittersweet symphony","volume":"11","author":"Rodrigues","year":"2015","journal-title":"PLoS Pathog."},{"key":"B106","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.140.4.1274","article-title":"Effective immunization against cutaneous leishmaniasis with defined membrane-antigens reconstituted into liposomes","volume":"140","author":"Russell","year":"1988","journal-title":"J. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of hemophilus-influenzae type-B polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J. Exp. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.micinf.2007.02.010","article-title":"Rational approaches to developing an anti-disease vaccine against malaria","volume":"9","author":"Schofield","year":"2007","journal-title":"Microb. Infect."},{"key":"B109","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nri1686","article-title":"Immunological processes in malaria pathogenesis","volume":"5","author":"Schofield","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1084\/jem.177.1.145","article-title":"Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites","volume":"177","author":"Schofield","year":"1993","journal-title":"J. Exp. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nature00937","article-title":"Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria","volume":"418","author":"Schofield","year":"2002","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/00034983.1993.11812820","article-title":"Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria","volume":"87","author":"Schofield","year":"1993","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"B114","volume-title":"Chemical Glycomics \u2013 From Carbohydrate Arrays to a Malaria Vaccine","author":"Seeberger","year":"2007"},{"key":"B115","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect. Dis. Poverty"},{"key":"B116","doi-asserted-by":"publisher","first-page":"9258","DOI":"10.1073\/pnas.160257897","article-title":"Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite leishmania major","volume":"97","author":"Spath","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B117","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J. Infect. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1016\/j.bmc.2010.04.059","article-title":"Synthetic glycosylphosphatidylinositol microarray reveals differential antibody levels and fine specificities in children with mild and severe malaria","volume":"18","author":"Tamborrini","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"B119","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.50.5.687","article-title":"Cutaneous reactions to the polysaccharides and proteins of pneumococcus in lobar pneumonia","volume":"50","author":"Tillett","year":"1929","journal-title":"J. Exp. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Tinto","year":"2015","journal-title":"Lancet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1423-0127-20-35","article-title":"Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis","volume":"20","author":"Topuzogullari","year":"2013","journal-title":"J. Biomed. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"11438","DOI":"10.1002\/anie.201203912","article-title":"Chemical biology of glycosylphosphatidylinositol anchors","volume":"51","author":"Tsai","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"B123","volume-title":"Biological Roles of Glycans. Essentials of Glycobiology","author":"Varki","year":"2009"},{"key":"B124","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"Velez","year":"2005","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.febslet.2006.03.053","article-title":"Carbohydrate based vaccines","volume":"580","author":"Vliegenthart","year":"2006","journal-title":"FEBS Lett."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","article-title":"Immunology of bacterial polysaccharide antigens","volume":"338","author":"Weintraub","year":"2003","journal-title":"Carbohydr. Res."},{"key":"B127","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1128\/IAI.61.11.4760-4766.1993","article-title":"Stimulation of protective antibodies against type-Ia and type-Ib group-B streptococci by a type-Ia polysaccharide-tetanus toxoid conjugate vaccine","volume":"61","author":"Wessels","year":"1993","journal-title":"Infect. Immun."},{"key":"B128","volume-title":"Malaria Vaccine Technology Roadmap","year":""},{"key":"B129","volume-title":"World Malaria Report 2013","year":""},{"key":"B130","volume-title":"WHO 2014 World Malaria Report","year":"2014"},{"key":"B131","unstructured":""},{"key":"B132","volume-title":"Malaria Vaccine","year":""},{"key":"B132a","unstructured":"Leishmaniasis - The Disease and its Epidemiology2017"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1084\/jem.187.8.1335","article-title":"Tolerization of anti-Gal alpha 1-3Gal natural antibody-forming B cells by induction of mixed chimerism","volume":"187","author":"Yang","year":"1998","journal-title":"J. Exp. Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cell.2014.10.053","article-title":"Gut microbiota elicits a protective immune response against malaria transmission","volume":"159","author":"Yilmaz","year":"2014","journal-title":"Cell"},{"key":"B135","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4939-2874-3_2","article-title":"Glycans as vaccine antigens and adjuvants: immunological Considerations","author":"Zimmermann","year":"2015"},{"key":"B136","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.21.120601.141045","article-title":"On natural and artificial vaccinations","volume":"21","author":"Zinkernagel","year":"2003","journal-title":"Annu. Rev. Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00248\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:29:06Z","timestamp":1692836946000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00248\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":136,"alternative-id":["10.3389\/fcimb.2017.00248"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00248","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]},"article-number":"248"}}